Radiation and Musculoskeletal Safety

By Eric A. Secemsky, MD, MSc

Minimizing Exposure, Maximizing Safety: Cath Lab Radiation Protection

Balancing safety, comfort, and operational efficiency in a high-risk environment.

By Taishi Hirai, MD, FACC, FSCAI; Jeremy D. Rier, DO, FACC, FSCAI; and Rhian E. Davies, DO, MS, FACC, FSCAI

SCAI’s Approach to Radiation and Occupational Safety

Insights from SCAI leadership on findings from a recent societal survey on occupational hazards and the efforts the society is making to prioritize physician health and safety.

By Allison Dupont, MD, FSCAI, and James Hermiller, MD, MSCAI

Radiation and MSK Safety in the Real World

Reflections on the historical lack of awareness regarding radiation and musculoskeletal issues and what is changing the conversation, the hospital’s role in ensuring staff safety, and ideal next steps.

With Ajar Kochar, MD, MHS; Sheila Sahni, MD, FACC, FSCAI; and William A. Gray, MD, MSCAI, FACC

MSK Injuries: What the Next Generation Must Understand Now

The effects of radiation protection on musculoskeletal injury and how the field has responded, changes to alleviate the burden of lead, recommendations for younger practitioners, and the role of administrators and industry.

With Kenneth Rosenfield, MD, MHCDS

Literature Highlights: Study Finds Lower Operator Radiation Exposure With Left Radial Versus Hyperadducted Right Radial Artery Approach

With Richard Casazza, MAS; Arsalan T. Hashmi, MD; Bilal Malik, MD; and Jacob Shani, MD

HTN Practice and Team Building

Early adopters/referrers of RDN for hypertension discuss keys to successfully starting a dedicated practice, advice for developing referrer relationships, tips for reaching patients, and more.

With Tiffany C. Randolph, MD, MHA, FACC; Michael J. Bloch, MD, FAHA, FASH, FNLA, FSVM, FACP; and Anna K. Krawisz, MD

The State of Reimbursement for Renal Denervation in the United States

As renal denervation is adopted across the United States for patients with uncontrolled or resistant hypertension, the dubious state of reimbursement presents a barrier to both health systems and patients seeking the procedure.

By Catherine Vanchiere, MD, MA; Tayyab Shah, MD; Debbie L. Cohen, MD; Jay Giri, MD, MPH; Brian Fulton, MD; and Taisei Kobayashi, MD

Next Frontiers in HTN Denervation

Reflections on the next generation of RDN trials and their potential endpoints, how to handle data collection, and new applications beyond renal.

With Felix Mahfoud, MD, MA; Ajay J. Kirtane, MD; and Andrew Sharp, MD

From Individuals to Impact: Building Teams to Drive Quality and Performance in ASC Cath Labs

Strategic staffing in ambulatory surgical centers is crucial for high-quality, cost-effective interventional cardiology care.

By Ginger Biesbrock, DSc, PA-C, MPH, FACC

Exploring the Role of Interventional Cardiologists in Cardio-Oncology

Leading experts in cardio-oncology discuss where the interventional cardiologist fits in the cardio-oncology field, challenges to treating cancer patients in the cath lab, treatment considerations for TAVR in a cancer patient, and advice for interested trainees.

With Mehmet Çilingiroğlu, MD; Konstantinos Marmagkiolis, MD, MBA, FACC, FSCAI; and Cezar Iliescu, MD, FACC, FSCAI